JP Morgan Chase
AGN

JP Morgan Chase’s Allergan plc AGN Stock Holding History

JP Morgan Chase’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,000
Closed -$3.82M – 5936
2019
Q4 		$3.82M Sell
20,000
-214,500
-91% -$38.7M ﹤0.01% 2901
2019
Q3 		$39.5M Sell
234,500
-219,800
-48% -$35.8M 0.01% 1074
2019
Q2 		$75.4M Buy
+454,300
New +$62.9M 0.01% 780
2019
Q1 		– Sell
-108,600
Closed -$14.5M – 6183
2018
Q4 		$14.5M Sell
108,600
-68,500
-39% -$11.2M ﹤0.01% 1730
2018
Q3 		$33.7M Buy
177,100
+106,000
+149% +$19.5M 0.01% 1270
2018
Q2 		$11.9M Sell
71,100
-107,000
-60% -$17.2M ﹤0.01% 2003
2018
Q1 		$30M Buy
+178,100
New +$29.9M 0.01% 1252
2017
Q4 		– Sell
-72,500
Closed -$14.8M – 5669
2017
Q3 		$14.8M Sell
72,500
-1,919
-3% -$446K ﹤0.01% 1704
2017
Q2 		$18.1M Buy
74,419
+57,272
+334% +$13.5M ﹤0.01% 1525
2017
Q1 		$4.1M Sell
17,147
-38,353
-69% -$8.93M ﹤0.01% 2570
2016
Q4 		$11.7M Buy
55,500
+34,013
+158% +$7.05M ﹤0.01% 1817
2016
Q3 		$4.95M Sell
21,487
-637,200
-97% -$156M ﹤0.01% 2268
2016
Q2 		$152M Buy
658,687
+626,187
+1,927% +$144M 0.04% 440
2016
Q1 		$8.71M Sell
32,500
-149,300
-82% -$42.7M ﹤0.01% 1850
2015
Q4 		$56.8M Buy
181,800
+37,600
+26% +$11.2M 0.01% 755
2015
Q3 		$39.2M Buy
144,200
+94,200
+188% +$28.9M 0.01% 901
2015
Q2 		$15.2M Sell
50,000
-318,900
-86% -$95.1M ﹤0.01% 1601
2015
Q1 		$110M Buy
368,900
+262,500
+247% +$74.8M 0.03% 601
2014
Q4 		$27.4M Buy
106,400
+95,400
+867% +$23.8M 0.01% 1272
2014
Q3 		$2.65M Buy
+11,000
New +$2.46M ﹤0.01% 2745

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

JP Morgan Chase's AGN Position: Q2 2020 in Review

JP Morgan Chase sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,705,099 shares — an estimated $656M sold.

JP Morgan Chase first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $2.07B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • JP Morgan Chase reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • JP Morgan Chase sold 3,705,099 Allergan plc shares in Q2 2020, an estimated $656M.
  • JP Morgan Chase first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • JP Morgan Chase's Allergan plc position peaked at $2.07B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.